Home
5436 All Specialties
1417 Arthroplasty
534 Shoulder & Elbow
504 Sports Medicine
498 Spine
491 Trauma
476 Physical Therapy & Rehab
474 Osteoarthritis
292 Foot & Ankle
283 General Orthopaedics
254 Hand & Wrist
79 Metabolic Disorders
67 Pediatric Orthopaedics
48 Cannabis
19 Tumour
OE Plus
1 OE Recommends
49 OE Originals
20 OrthoPODS
42 Conferences
149 Exclusive Interviews
15 Evidence Series
7 Ace Reviews
CME
PeerView
Orthopaedic Surgeon
Primary Care Physician
Physiotherapist
Occupational Therapist
Sports Medicine Specialist
Orthopaedic Resident/Intern
Loading...
Loading...
Search Filters

Date Range

to

Report Types

ALL
RCT
META
ACE Reviews

Specialties

See all (14)

Emerging Treatments

OE Recommends Topics

Multimedia

Journal

Conference Series

Evidence Series

We found 1 results matching your search query: "Algeta"

Showing 1 - 1 of 1
Read Ace Report

Early vs standard zoledronic acid treatments for prostate cancer metastatic to bone

J Clin Oncol. 2014 Apr 10;32(11):1143-50. doi: 10.1200/JCO.2013.51.6500.

RCT Tumour Metastasis Algeta Amgen Aventis Bayer EXINI Diagnostics Novartis Sanofi Zoledronic Acid - Hide
Showing 1 - 1 of 1